Fast syndromic diagnostic testing helps the healthcare providers to deliver efficient and timely patient centered care. It greatly reduces diagnostic uncertainty, and helps overcome mistakes and inefficiencies that commonly result from testing one or few organisms at a time.
Testing multiple pathogens in a single test reaction is known as multiplexing. Multiplex molecular syndromic testing gives answers that are more accurate, comprehensive, and actionable for real-life decisions in critical care.Current technologies offer the potential to have a definitive diagnosis in about 1 hour, allowing timely decisions about treatment, hospital admission, infection control, antimicrobial stewardship and outbreak tracking. Several studies demonstrate how using panels to detect multiple pathogens at once is associated with both improvements in clinical practice and better outcomes, from increased diagnostic yield, greater diagnostic accuracy, to less use of resources, antibiotic use and reduced overall length of stay.
In addition, Multiplex molecular syndromic testing greatly reduces inefficiencies, uncertainties, and mistakes, thus supports laboratory stewardship.